Managing Director, Berkeley Research Group
Dan Troy is Managing Director and an expert witness on FDA matters at Berkeley Research Group. Previously he served as Chief Counsel of the US Food and Drug Administration and General Counsel of GlaxoSmithKline PLC.
Managing Director, Berkeley Research Group
Dan Troy is Managing Director and an expert witness on FDA matters at Berkeley Research Group. Previously he served as Chief Counsel of the US Food and Drug Administration and General Counsel of GlaxoSmithKline PLC.
FDA Labeling and State Liability
Daniel E. Troy
Were state and federal courts to defer sufficiently to FDA determinations of drug safety, the...
FDA Censorship Could Cost Lives
Daniel E. Troy
Last month brought news that an inexpensive generic drug is remarkably effective in reducing congestive...
FDA Modernization and Accountability Act of 1997: A Blueprint for Reform
Nick Littlefield, Sharon Webb
On the afternoon of Sunday, November 9, 1997, in the middle of the long Veterans...